cj red bio anticancer drug

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US,  has applied to the Australian clini...

Croda International Plc., a British specialty chemicals company, is set to acquire South Korean bio materials producer Solus Biotech Co. for some 35...

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...

South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...

South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...

South Korea's venture capital investment last year fell more than 10% from a year ago due to the economic downturn caused by a series of global rate...

South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...

South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big dat...

South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...

POSCO Holdings Inc., the holding company of South Korea’s top steelmaker, turned to the red in the fourth quarter of 2022 hit by a typhoon and...

South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...

ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...

South Korea's CJ HDC Biosol on Thursday said it held a completion ceremony for its biodegradable material compounding plant at Gwanghyewon Industria...

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...

SAN FRANCISCO – SK Inc.,  the investment and holding company of South Korea’s SK Group, expects significant growth in its biopharma...

SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...

Pacific Alliance Group (PAG), a Hong Kong-based alternative investment firm, joined the bidding on Jan. 10 to acquire a 100% stake in South Korean h...

South Korea in November last year suffered its second current account deficit in three months due to plummeting exports of key items like semiconduc...

SK Inc., the investment company of SK Group, said on Tuesday that it will hold a networking event called "SK Bio Night" in the US along with its bio...

Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...

South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...

South Korean food giant CJ CheilJedang Corp. is slated to increase food manufacturing facilities globally and launch businesses in Australia, Canada...

Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...

South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

South Korea’s National Pension Service (NPS), the world’s third-largest such fund, is poised to report an annual loss in 2022 for the fi...